DAVID ANDERSON: Open Payments
NPI 1649303165 · ATASCADERO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,637 in 99 payments from 15 companies in 2025. Trend: 2023 $541 · 2024 $2,443 · 2025 $2,637
Food & beverage: $2,522Education: $115
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $343 |
| Regeneron Healthcare Solutions, Inc. | 8 | $317 |
| AstraZeneca Pharmaceuticals LP | 5 | $314 |
| GlaxoSmithKline, LLC. | 17 | $299 |
| Philips North America LLC | 12 | $263 |
| Verona Pharma, Inc. | 9 | $244 |
| Electromed, Inc. | 9 | $183 |
| Insmed, Inc. | 10 | $172 |
| Madrigal Pharmaceuticals | 1 | $123 |
| Novo Nordisk Inc | 1 | $110 |
Products named: TEZSPIRE, DUPIXENT, Vest Therapy Und, Ohtuvayre, SMARTVEST, Arikayce, TRELEGY ELLIPTA, NUCALA.
Industry payments across CA — which companies pay providers there.
